-+ 0.00%
-+ 0.00%
-+ 0.00%

Stephens & Co. Reiterates Overweight on Actinium Pharma, Maintains $5 Price Target

Benzinga·03/31/2026 13:08:28
Listen to the news
Stephens & Co. analyst Sudan Loganathan reiterates Actinium Pharma (AMEX:ATNM) with a Overweight and maintains $5 price target.